Last reviewed · How we verify

Oral L-ornithine aspartate administration — Competitive Intelligence Brief

Oral L-ornithine aspartate administration (Oral L-ornithine aspartate administration) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Amino acid supplement. Area: Gastroenterology.

phase 3 Amino acid supplement Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Oral L-ornithine aspartate administration (Oral L-ornithine aspartate administration) — Ukrainian Medical Stomatological Academy. Oral L-ornithine aspartate administration increases ornithine levels in the body.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Oral L-ornithine aspartate administration TARGET Oral L-ornithine aspartate administration Ukrainian Medical Stomatological Academy phase 3 Amino acid supplement
L-Arginine L-Arginine The University of Texas at Arlington marketed Amino acid supplement Nitric oxide synthase substrate
L-arginine (L-arginine Veyron) L-arginine (L-arginine Veyron) University Hospital, Strasbourg, France marketed Amino acid supplement Nitric oxide synthase (substrate)
L-Carnitine ( high dose) L-Carnitine ( high dose) Ain Shams University marketed Amino acid supplement / Metabolic agent Carnitine palmitoyltransferase (CPT) system
5-Hydroxytryptophan 5-Hydroxytryptophan Elizabeth Berry-Kravis marketed Serotonin precursor / amino acid supplement Aromatic amino acid decarboxylase (enzyme substrate); indirect serotonin system modulation
L-Tryptophan L-Tryptophan McMaster University marketed Amino acid supplement
L-Serine L-Serine Elijah W. Stommel marketed Amino acid supplement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Amino acid supplement class)

  1. Air Force Military Medical University, China · 1 drug in this class
  2. Elijah W. Stommel · 1 drug in this class
  3. Hadassah Medical Organization · 1 drug in this class
  4. Keith D Lindor, M.D. · 1 drug in this class
  5. McMaster University · 1 drug in this class
  6. The University of Texas at Arlington · 1 drug in this class
  7. Ukrainian Medical Stomatological Academy · 1 drug in this class
  8. University Hospital, Strasbourg, France · 1 drug in this class
  9. University of Colorado, Denver · 1 drug in this class
  10. University of Miami · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Oral L-ornithine aspartate administration — Competitive Intelligence Brief. https://druglandscape.com/ci/oral-l-ornithine-aspartate-administration. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: